Does acid suppression by antacids and H2 receptor antagonists increase the incidence of atrophic gastritis in patients with or without H. pylori gastritis?

Journal of Clinical Gastroenterology

Volumn 29, Issue 2, 1999, Pages 183-187

  Carter, Michele ^a,b   Katz, David L ^a,b   Haque, Salima ^b,c   DeLuca Jr , Vincent A ^a,b  

^a GRIFFIN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid suppression; Antacids; Atrophic gastritis; H. pylori; H2 receptor antagonists

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH PH;

AGED; ANTACIDS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0032807607     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199909000-00016     Document Type: Article

References (11)

1. Kiupers EJ, Sundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
2. Haque S, Ciarolla D, Wain S, DeLuca VA. Helicobacter pylori. The stomach and progression of gastritis - a 14 year follow-up. Gastroenterology 1992;102:A79.
3. DeLuca VA, West AB, Haque S, Ciarolla D, Goldenberg S, Fette G. Helicobacter pylori - a 12.3 year followup. Histological progression to atrophic gastritis. Correlation with dyspepsia, endoscopy and serum pepsinogen. J Clin Gastroenterol 1998;26:106-12.
4. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
5. Lambert R, Crutzfeldt W, Stuber HG, Brenner G, Solcia E. Long term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth and gastritis. Gastroenterology 1993;104:1356-70.
6. Eissele R, Gorik B, Simar B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprozole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997;112: 707-17.
7. Lundell L, Havu N, Andersson P, et al. Gastritis development and acid suppression therapy revisited. Results of a randomized clinical study with long-term followup. Gastroenterology 1997;112(4): A28. Abstract.
8. Stote M, Bethke B, Blum AL, Sulser E, Stadelmann O. Antacid treatment has a deleterious effect on the severity and activity of gastritis of the corpus mucosa. Ir J Med Sci 1992:161(suppl 10):6. Abstract.
9. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;20(10):1161-81.
10. SAS Institute Inc. SAS/STAT user's guide. Version 6, 4th ed., vol. 1. Cary, NC: SAS Institute Inc., 1989:875.
11. Ihamaki T, Saukkone N, Siurala M. Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23-27 years' followup examinations. Scand J Gastroenterol 1978;13:1771-5.